ArticleDiabetology & metabolic syndrome2026
Association between different metabolic phenotypes and chronic kidney disease risk: a cohort study.
Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionMetabolic syndrome (MetS) involves conditions that alter renal structure/function; however few studies have considered the dynamic nature of metabolic status when exploring its association with chronic kidney disease (CKD).
methodsWe retrospectively included 7034 participants, categorized into four metabolic phenotypes by BMI and metabolic status: metabolically healthy non-overweight/obesity (MHNO), metabolically healthy overweight/obesity (MHO), metabolically unhealthy non-overweight/obesity (MUNO), and metabolically unhealthy overweight/obesity (MUO). The primary endpoint was incident CKD (eGFR < 60 ml/min/1.73 m² and/or proteinuria for two consecutive years). Associations were assessed using Cox and logistic regression analysis with multivariate adjustments.
resultsThe baseline proportions of individuals with MHNO, MUNO, MHO, and MUO phenotypes were 35.6%, 17.5%, 18.3%, and 28.6%, respectively. After multivariate adjustment in Cox analyses, MUNO (HR:1.184; 95%CI:1.031-1.506) and MUO (HR:1.420; 95%CI:1.153-1.749) phenotypes were associated with incident CKD, with no such association in the MHO phenotype. However, in terms of transitions, compared with those with a consistent MHNO phenotype, those with a MHO phenotype evolving to a metabolically unhealthy status had higher incident CKD risk (HR:1.649; 95%CI:1.096-2.482).
conclusionOverweight/obesity and metabolic unhealthy status increase CKD risk; individuals with MHO who transition to metabolically unhealthy phenotypes have higher CKD risk than those consistently maintaining MHNO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.